Aptinyx to Present Detailed Results from Phase 2 Painful DPN Study of NYX – 2925 at American Pain Society Scientific Meeting by mparnell | Mar 28, 2019 | Portfolio News
Velicept Therapeutics Announces Positive Top-Line Phase 2b Results for Solabegron in the Treatment of Overactive Bladder (OAB) by mparnell | Mar 28, 2019 | Portfolio News
Tricida Announces Positive Results From Long-Term Clinical Trial of TRC101 in Patients With CKD and Metabolic Acidosis by mparnell | Mar 28, 2019 | Portfolio News
Tricida Announces $200 Million Debt Facility With Hercules Capital by mparnell | Mar 28, 2019 | Portfolio News
Tricida Announces Fourth Quarter and Full-Year 2018 Financial Results by mparnell | Mar 28, 2019 | Portfolio News